• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.溃疡性结肠炎中皮质类固醇与柳氮磺胺吡啶疗法的比较。
Br Med J. 1962 Dec 29;2(5321):1708-11. doi: 10.1136/bmj.2.5321.1708.
2
Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.柳氮磺胺吡啶和水杨酸偶氮磺胺嘧啶治疗溃疡性结肠炎
Lancet. 1962 May 26;1(7239):1094-6. doi: 10.1016/s0140-6736(62)92080-9.
3
Medical management of ulcerative colitis.溃疡性结肠炎的医学管理
Br Med J. 1961 Jan 21;1(5220):147-51. doi: 10.1136/bmj.1.5220.147.
4
A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis.柳氮磺胺吡啶在慢性溃疡性结肠炎中的应用批判性分析。
Ann Intern Med. 1959 Nov;51:879-89. doi: 10.7326/0003-4819-51-5-879.
5
Studies of the bone marrow in immunological granulocytopenia; following administration of salicylazosulfapyridine.免疫性粒细胞减少症患者骨髓的研究；在给予柳氮磺胺吡啶之后。
AMA Arch Intern Med. 1958 Feb;101(2):244-51. doi: 10.1001/archinte.1958.00260140076012.
6
An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.对泼尼松、柳氮磺胺吡啶和局部用半琥珀酸氢化可的松作为溃疡性结肠炎门诊治疗药物的评估。
Gut. 1960 Sep;1(3):217-22. doi: 10.1136/gut.1.3.217.
7
[ULCERATIVE COLITIS].[溃疡性结肠炎]
Ther Ggw. 1963 Aug;102:925-8.
8
THE TREATMENT OF ULCERATIVE COLITIS: ANALYSIS OF 82 CASES.溃疡性结肠炎的治疗：82例病例分析。
J Med Soc N J. 1963 Mar;60:105-8.
9
Response of ulcerative colitis to therapy with salicylazosulfapyridine.溃疡性结肠炎对柳氮磺胺吡啶治疗的反应。
J Am Med Assoc. 1953 Jan 31;151(5):366-8.
10
[Ulcerative colitis and its therapy, especially with azulfidine].[溃疡性结肠炎及其治疗，尤其是柳氮磺胺吡啶治疗]
Munch Med Wochenschr. 1961 Aug 18;103:1576-8.

引用本文的文献

1
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial.活动性溃疡性结肠炎中与全身用皮质类固醇反应相关的因素：一项前瞻性多中心试验的结果
J Clin Med. 2023 Jul 24;12(14):4853. doi: 10.3390/jcm12144853.
2
Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice.临床实践中溃疡性结肠炎糖皮质激素初始剂量及减量率分析
JGH Open. 2022 Aug 20;6(9):612-620. doi: 10.1002/jgh3.12796. eCollection 2022 Sep.
3
Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.粪便微生物群移植与糖皮质激素治疗轻中度溃疡性结肠炎诱导缓解的比较。
J Transl Med. 2022 Aug 12;20(1):354. doi: 10.1186/s12967-022-03569-3.
4
Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice.炎症性肠病中的糖皮质激素治疗：机制与临床实践。
Front Immunol. 2021 Jun 3;12:691480. doi: 10.3389/fimmu.2021.691480. eCollection 2021.
5
Steroid use and misuse: a key performance indicator in the management of IBD.类固醇的使用与滥用：炎症性肠病管理中的一项关键绩效指标。
Frontline Gastroenterol. 2020 Apr 2;12(3):207-213. doi: 10.1136/flgastro-2019-101288. eCollection 2021.
6
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.英国胃肠病学会成人炎症性肠病管理共识指南。
Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27.
7
Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis.用于治疗溃疡性结肠炎的布地奈德pH敏感纳米颗粒的制备与表征
Drug Des Devel Ther. 2018 Aug 22;12:2601-2609. doi: 10.2147/DDDT.S170676. eCollection 2018.
8
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.炎症性肠病的糖皮质激素治疗：从临床实践到分子生物学。
World J Gastroenterol. 2017 Sep 28;23(36):6628-6638. doi: 10.3748/wjg.v23.i36.6628.
9
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?炎症性肠病治疗的临床应答和缓解时间：临床医生应该期待什么，应该告诉患者什么？
World J Gastroenterol. 2017 Sep 21;23(35):6385-6402. doi: 10.3748/wjg.v23.i35.6385.
10
Budesonide for the treatment of ulcerative colitis.布地奈德用于治疗溃疡性结肠炎。
Expert Opin Pharmacother. 2016 Aug;17(11):1549-59. doi: 10.1080/14656566.2016.1183648. Epub 2016 Jun 16.

本文引用的文献

1
The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report.肾上腺皮质激素（17-羟基-11-脱氢皮质酮：化合物E）及垂体促肾上腺皮质激素在关节炎中的作用：初步报告
Ann Rheum Dis. 1949 Jun;8(2):97-104. doi: 10.1136/ard.8.2.97.
2
Results of treatment of ulcerative colitis with salicylazosulfapyridine.柳氮磺胺吡啶治疗溃疡性结肠炎的结果
Gastroenterology. 1952 May;21(1):133-8.
3
A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis.柳氮磺胺吡啶在慢性溃疡性结肠炎中的应用批判性分析。
Ann Intern Med. 1959 Nov;51:879-89. doi: 10.7326/0003-4819-51-5-879.
4
Sulphasalazine and salicylazosulphadimidine in ulcerative colitis.柳氮磺胺吡啶和水杨酸偶氮磺胺嘧啶治疗溃疡性结肠炎
Lancet. 1962 May 26;1(7239):1094-6. doi: 10.1016/s0140-6736(62)92080-9.
5
An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.对泼尼松、柳氮磺胺吡啶和局部用半琥珀酸氢化可的松作为溃疡性结肠炎门诊治疗药物的评估。
Gut. 1960 Sep;1(3):217-22. doi: 10.1136/gut.1.3.217.
6
Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis.用半琥珀酸氢化可的松钠局部治疗溃疡性结肠炎；一项采用受限序贯分析的对照试验。
Br Med J. 1958 Nov 1;2(5104):1077-82. doi: 10.1136/bmj.2.5104.1077.
7
Treatment of ulcerative colitis with local hydrocortisone.局部应用氢化可的松治疗溃疡性结肠炎。
Br Med J. 1956 Dec 1;2(5004):1267-72. doi: 10.1136/bmj.2.5004.1267.
8
Cortisone in ulcerative colitis; final report on a therapeutic trial.可的松治疗溃疡性结肠炎；一项治疗试验的最终报告
Br Med J. 1955 Oct 29;2(4947):1041-8. doi: 10.1136/bmj.2.4947.1041.

Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.

作者信息

TRUELOVE S C, WATKINSON G, DRAPER G

出版信息

Br Med J. 1962 Dec 29;2(5321):1708-11. doi: 10.1136/bmj.2.5321.1708.

DOI:10.1136/bmj.2.5321.1708
PMID:13994348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1926962/
Abstract
摘要